|
Name |
1-Octadecene
|
Molecular Formula | C18H36 | |
IUPAC Name* |
octadec-1-ene
|
|
SMILES |
CCCCCCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C18H36/c1-3-5-7-9-11-13-15-17-18-16-14-12-10-8-6-4-2/h3H,1,4-18H2,2H3
|
|
InChIKey |
CCCMONHAUSKTEQ-UHFFFAOYSA-N
|
|
Synonyms |
1-OCTADECENE; Octadec-1-ene; 112-88-9; OCTADECENE; alpha-Octadecene; .alpha.-Octadecene; Octadecene-1; H5ZUQ6V4AK; 27070-58-2; CHEBI:30824; NSC-66460; Alkenes, C14-20 .alpha.-; 1-Octadecene, analytical standard; Octadecylene alpha-; UNII-H5ZUQ6V4AK; 1-octadecen; alpha-octadecylene; octadeca-1-ene; 1-Octadene; Neodene 18; EINECS 204-012-9; EINECS 248-205-6; NSC 66460; Octadecylene .alpha.-; Octadecylene, .alpha.-; AI3-06521; OCTADECENE [INCI]; OCTADECENE, 1-; DSSTox_CID_6932; EC 204-012-9; EC 248-205-6; DSSTox_RID_78260; DSSTox_GSID_26932; CHEMBL3187417; DTXSID3026932; 1- octadecene, alpha- octadecene; NSC66460; Tox21_202739; 1-Octadecene, >=95.0% (GC); LMFA11000325; MFCD00009003; ZINC59696736; 1-Octadecene, technical grade, 90%; AKOS015904365; 1-Octadecene, technical, ~85% (GC); 1-octadecene [standard material for gc]; NCGC00260287-01; BS-42192; CAS-112-88-9; DB-041130; FT-0608173; O0008; S0348; F71291; J-002862; W-108634; Q10859725
|
|
CAS | 112-88-9 | |
PubChem CID | 8217 | |
ChEMBL ID | CHEMBL3187417 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 252.5 | ALogp: | 10.0 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 18 | QED Weighted: | 0.218 |
Caco-2 Permeability: | -4.833 | MDCK Permeability: | 0.00000987 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.183 |
30% Bioavailability (F30%): | 0.884 |
Blood-Brain-Barrier Penetration (BBB): | 0.135 | Plasma Protein Binding (PPB): | 100.29% |
Volume Distribution (VD): | 3.168 | Fu: | 1.10% |
CYP1A2-inhibitor: | 0.243 | CYP1A2-substrate: | 0.184 |
CYP2C19-inhibitor: | 0.369 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.106 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.343 | CYP2D6-substrate: | 0.203 |
CYP3A4-inhibitor: | 0.408 | CYP3A4-substrate: | 0.053 |
Clearance (CL): | 4.337 | Half-life (T1/2): | 0.056 |
hERG Blockers: | 0.164 | Human Hepatotoxicity (H-HT): | 0.008 |
Drug-inuced Liver Injury (DILI): | 0.054 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.04 |
Skin Sensitization: | 0.968 | Carcinogencity: | 0.051 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.952 |
Respiratory Toxicity: | 0.29 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000589 | 0.945 | D07ILQ | 0.600 | ||||
ENC000557 | 0.942 | D00AOJ | 0.587 | ||||
ENC000425 | 0.885 | D0Z5SM | 0.559 | ||||
ENC000573 | 0.827 | D00FGR | 0.530 | ||||
ENC000715 | 0.813 | D0O1PH | 0.494 | ||||
ENC000082 | 0.772 | D05ATI | 0.478 | ||||
ENC000427 | 0.772 | D0Z5BC | 0.419 | ||||
ENC000380 | 0.772 | D00STJ | 0.361 | ||||
ENC000475 | 0.769 | D0P1RL | 0.352 | ||||
ENC001707 | 0.746 | D0T9TJ | 0.351 |